ActivistsInvestorsTrumpPoliticiansSerenityCitriniSemianalysisTradeArbitrageSearch
By filer · By stock

$ALKS:NASDAQ · ALKERMES PLC

Sector: health

Conviction from: NASDAQ

Alkermes is a biopharmaceutical company that develops and commercializes medicines for central nervous system disorders, including addiction and schizophrenia treatments.

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 31-MAR-2026

Aggregate 13FScore 56 — mean of 2 scored holder(s) · buyers (new/add) avg 56. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Louis Bacon / Moore56New buy158,499$5,604,5250.1%
Bridgewater55Trimmed -76%83,806$2,963,3800.0%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

4 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-01Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentBUY$50,001 - $100,000PTR
2026-05-14Trump, Donald J PresidentBUY$15,001 - $50,000PTR
2026-05-14Trump, Donald J PresidentBUY$15,001 - $50,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.